Finnegan Kevin 4
4 · New York & Company, Inc. · Filed Dec 17, 2012
Insider Transaction Report
Form 4
Finnegan Kevin
EVP, Global Sales & Operations
Transactions
- Sale
Common Stock
2012-12-14$3.41/sh−30,973$105,618→ 145,613 total - Sale
Common Stock
2012-12-13$3.37/sh−47,214$159,111→ 176,586 total - Sale
Common Stock
2012-12-17$3.51/sh−43,112$151,323→ 102,501 total
Holdings
- 4,372(indirect: By Trust)
Common Stock
- 20,000
Options to Purchase Common Stock
Exercise: $4.74Exp: 2018-03-19→ Common Stock (20,000 underlying) - 8,919
Options to Purchase Common Stock
Exercise: $3.28Exp: 2017-03-21→ Common Stock (8,919 underlying) - 50,000
Stock Appreciation Rights
Exercise: $3.65Exp: 2022-04-16→ Common Stock (50,000 underlying) - 50,000
Stock Appreciation Rights
Exercise: $4.79Exp: 2020-04-01→ Common Stock (50,000 underlying) - 40,000
Stock Appreciation Rights
Exercise: $6.89Exp: 2021-04-15→ Common Stock (40,000 underlying) - 30,000
Options to Purchase Common Stock
Exercise: $2.86Exp: 2019-03-18→ Common Stock (30,000 underlying)
Footnotes (7)
- [F1]Includes 10,001 shares of common stock, 10,000 shares of restricted stock which vests on April 16, 2015, 7,500 shares of restricted stock which vests on April 15, 2014 and 75,000 shares of restricted stock which vests on April 1, 2013.
- [F2]Represents common stock indirectly beneficially owned through the Kevin L. Finnegan 2004 Grantor Retained Annuity Trust.
- [F3]The stock appreciation rights (SARs) vest on April 15, 2014. Each SAR represents the right to receive a payment measured by the increase in the fair market value of one share of common stock from the date of grant of the SAR to the date of exercise of the SAR. Upon exercise the SARs will be settled in stock.
- [F4]The SARs vest on April 1, 2013. Each SAR represents the right to receive a payment measured by the increase in the fair market value of one share of common stock from the date of grant of the SAR to the date of exercise of the SAR. Upon exercise the SARs will be settled in stock.
- [F5]The options become exercisable in four annual installments on the following dates: 7,500 shares on March 18, 2010; 7,500 shares on March 18, 2011; 7,500 shares on March 18, 2012; and 7,500 shares on March 18, 2013.
- [F6]The options are exercisable.
- [F7]The SARs vest on April 16, 2015. Each SAR represents the right to receive a payment measured by the increase in the fair market value of one share of common stock from the date of grant of the SAR to the date of exercise of the SAR. Upon exercise the SARs will be settled in stock.